These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12387104)

  • 21. 'DOTS' and 'DOT' for delivering antiretroviral therapy in resource-poor countries.
    Harries AD
    AIDS; 2004 Mar; 18(5):830-1; author reply 831-2. PubMed ID: 15075526
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV/AIDS medicines pricing report. Setting objectives: is there a political will?
    Pérez-Casas C
    BETA; 2001; 13(4):17-21. PubMed ID: 11693076
    [No Abstract]   [Full Text] [Related]  

  • 23. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 24. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 25. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmaceutical industry's corporate social responsibility towards HIV/AIDS.
    Khanna AK
    J Postgrad Med; 2006; 52(3):194-6. PubMed ID: 16855320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
    James JS
    AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FUZEON (enfuvirtide, T-20). Breaking barriers or breaking the bank?
    Sharp M; Camp R
    GMHC Treat Issues; 2003 Mar; 17(3):7-8. PubMed ID: 12728858
    [No Abstract]   [Full Text] [Related]  

  • 29. AIDS research. Drug trials without the drugs?
    Cohen J
    Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159
    [No Abstract]   [Full Text] [Related]  

  • 30. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.
    Behforouz HL; Farmer PE; Mukherjee JS
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S429-36. PubMed ID: 15156434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report.
    Herrmann S; Wardrop J; John M; Gaudieri S; Lucas M; Mallal S; Nolan D
    Sex Health; 2012 Nov; 9(5):407-13. PubMed ID: 22950904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 33. Making the most of once-daily anti-HIV therapy.
    Cox S
    Posit Aware; 1998; 9(6):43. PubMed ID: 11366482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quest for an effective adherence intervention: a DOT-cART case study.
    Athey E
    J Assoc Nurses AIDS Care; 2014; 25(6):682-6. PubMed ID: 25305032
    [No Abstract]   [Full Text] [Related]  

  • 35. Expanding role of conformulations in the treatment of HIV infection: impact of fixed-dose combinations.
    Valenti WM
    AIDS Read; 2004 Oct; 14(10):541-3, 547-50. PubMed ID: 15510390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 37. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 38. India: New patent law may restrict access to HIV/AIDS treatments.
    Cruess G
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Editorial].
    Uribe Zúñiga P; Hernández Ávila M
    Salud Publica Mex; 2015; 57 Suppl 2():s97-8. PubMed ID: 26545136
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving access to essential drugs for people living with HIV/AIDS.
    Balasubramaniam K
    Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.